On Monday, June 12, the Committee on Accreditation of Canadian Medical Schools (CACMS) confirmed to McGill that the MDCM program is no longer on probation, effective immediately.
This positive outcome reflects the extraordinary work of many individuals, on campus and in our teaching network. On behalf of McGill and our Faculty of Medicine, congratulations.
As confirmed by the CACMS in its letter, the program remains accredited for an indeterminate term. We are “in compliance” or “in compliance with monitoring” for the majority of standards. We are rated “satisfactory” or “satisfactory with monitoring” for the majority of elements as well. Key areas of focus going forward relate to diversity within both the student body and leadership (Element 3.3) and supervision of students (Element 9.3), together with the elements that require monitoring. The CACMS has requested two status reports, the first for review in January 2019 and the second for review in January 2020.
We have crossed this milestone, one of many in our commitment to educational excellence. We are stronger today as a result, but our work, of course, is ongoing. We look forward to building on our progress and continually improving in all areas of the program to best prepare students to meet the evolving health care needs of our society.
I would like to express my appreciation to the CACMS Secretariat for their valuable guidance and input, as well as to the survey team members who visited us in February and reported their findings to the CACMS.
Last but not least, thank you, sincerely, to our students, leadership, academics and staff who stood up for educational excellence, and to our many alumni and friends who stood by McGill throughout.
Grandescunt Aucta Labore
-McGill University motto
David Eidelman, MDCM
Vice-Principal (Health Affairs)
Dean of the Faculty of Medicine
June 15, 2017